
AstraZeneca (LSE: AZN) has announced an integrated genomics initiative that aims to transform the drug discovery and development across is …

Human Longevity, the genomics-based, technology company, has appointed ‘several key people’ for its oncology genomics program.Dr Kenneth Bloom will join …

Genentech is partnering with US genetics firm Human Longevity (HLI) in another 2015 genomics deal to continue its push into …
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact

